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A Mutation in LIPN, Encoding Epidermal
Lipase N, Causes a Late-Onset Form
of Autosomal-Recessive Congenital Ichthyosis
Shirli Israeli,1,2,4 Ziyad Khamaysi,3,4 Dana Fuchs-Telem,1,2,4 Janna Nousbeck,1 Reuven Bergman,3
Ofer Sarig,1 and Eli Sprecher1,2,*
Autosomal-recessive congenital ichthyoses represent a large and heterogeneous group of disorders of epidermal cornification. Recent
data suggest that most of these disorders might result from defective lipid transport and metabolism. In the present study, we describe
a late-onset form of recessive ichthyosis in a large consanguineous pedigree. By using a combination of homozygositymapping and posi-
tional candidate-gene screening, we identified a 2 bp deletion in LIPN that segregated with the disease phenotype throughout the family.
LIPN encodes one of six acid lipases known to be involved in triglyceride metabolism in mammals . LIPN was found to be exclusively
expressed in the epidermis and to be strongly induced during keratinocyte differentiation.Autosomal-recessive congenital ichthyoses (ARCI) form
a complex and heterogeneous group of nonsyndromic
disorders of cornification (epidermal maturation) and
have an approximate prevalence of 1:100,000.1 Recent
data indicate that despite being rare, congenital ichthyoses
represent a major economical burden,2 suggesting the
need for improved preventive strategies as well as novel
therapeutic interventions.
ARCI patients can display generalized dry scaling of the
skin, known as lamellar ichthyosis (LI); alternatively, the
skin surface of ARCI patients can be diffusely red and
covered with fine whitish scales, a clinical presentation
referred to as congenital ichthyosiform erythroderma
(CIE). Some patients present with a particularly severe
disease form known as Harlequin ichthyosis (MIM
242500), in which the skin is covered by thick and
adherent scales;3 others display a phenotype that varies
in severity over time and that was recently coined pleo-
morphic ichthyosis4. ARCIs not only feature an unusual
degree of phenotypic heterogeneity, but they are also char-
acterized by extensive genetic heterogeneity, and seven
loci have been reported so far in various forms of ARCIs1
on 2q34 harboring ABCA12 (MIM 607800), 5q33.3
including NIPAL4 (MIM 609383), 14q11.2 harboring
TGM1 (MIM 190195), 17p13.1 spanning ALOX12B (MIM
603741), and ALOXE3 (MIM 607206), 19p13.12 contain-
ing CYP4F22 (MIM 611495), as well as additional intervals
in which no disease-associated variants have been identi-
fied so far.5–7
Despite these significant advances in our understanding
of ARCIs pathogenesis, no causative mutations can be
found in approximately one-fifth of ARCI cases.8 This is
likely due to the existence of mutations located either in
ARCI-associated gene regions that are not routinely
sequenced or in genes not previously associated with1Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv 64239
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locus on 10q23.31 and identified a pathogenicmutation in
LIPN, encoding lipase N, which was found to segregate
with the disease phenotype in a large consanguineous
family.
A 14-year-old girl of Arab Muslim origin was referred for
evaluation because of generalized scaling of the skin. At
birth, her skin looked normal; however, she developed
widespread ichthyosis at age 5 years of age. Her parents
were first-degree cousins. Six additional relatives were also
affected by a similar disorder (Figure 1). On examination,
the entire surface of her skin was covered with fine whitish
scales (Figures 2A and 2B), whereas her face was slightly
erythematous. Routine laboratory tests were normal. A
skin biopsy revealedhyperkeratosis and acanthosiswithout
evidence for epidermolytic changes or intracytoplasmic
vacuoles (Figure 2C).
A diagnosis of ARCI was posed. All affected and healthy
family members or their legal guardian provided written
and informed consent according to a protocol approved
by the institutional review board at the Tel Aviv Medical
Center and by the Israel National Committee for Human
Genetic Studies in adherence to the Helsinki guidelines.
DNA was extracted from peripheral blood lymphocytes.
We initially excluded all ARCI-associated loci by using a
panel of microsatellite markers, as previously reported.9,10
We therefore scrutinized the whole genome for regions
of homozygosity shared by all affected individuals by
using Illumina HumanLinkage-12 chip (Illumina Inc.)
that contains ~6000 tagged SNPs across the genome. Two
hundred nanograms of DNA was hybridized according to
the Infinium II assay (Illumina Inc.) and scanned with an
Illumina BeadArray reader. The scanned images were
imported into BeadStudio 3.1.3.0 (Illumina Inc.) for extrac-
tion and quality control and had an average call rate of, Israel; 2Department of HumanMolecular Genetics and Biochemistry, Sack-
tment of Dermatology, Rambam Medical Center, Haifa 31096, Israel
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Figure 1. Family Pedigree, Haplotype Analysis, and PCR-RFLP Analysis
The family tree appears in the upper panel (black symbols denote affected individuals and half-filled symbols represent heterozygous
carrier of mutation c.399_400delGA). Haplotype analysis using polymorphic markers on chromosome 10q23 is depicted in the middle
panel and reveals a homozygous haplotype shared by all patients (boxed in red). The lower panel provides details of the PCR-RFLP anal-
ysis that confirm segregation of the mutation in the family: mutation c.399_400delGA abolishes a recognition site for BsmAI; thus,
affected patients display a single fragment of 453 bp, healthy individuals show two fragments of 273 and 180 bp, and all fragments
are found in heterozygous carriers of the mutation.99.9%. The data were then scanned for homozygous
regions with a MatLab (MathWorks)-based software script.
We identified five regions of homozygosity larger than
2 Mb on 10q23 (13 Mb; 19 consecutive SNPs), 4q12
(7Mb; six consecutive SNPs), 19p11 (9Mb; five consecutive
SNPs), 4q31.3 (6 Mb; four consecutive SNPs), and 4q15.2
(2 Mb; four consecutive SNPs). Polymorphic microsatellite
markers spanning those five areas were selected from the
GeneLoc site. Genotypes were established by PCR amplifi-
cation of genomic DNA as previously described11 by using
the BigDye terminator system on an automated sequencer
(ABI PRISM 3100 Genetic Analyzer; Applied Biosystems,
Foster City, CA, USA), and allele sizes were determined
with GeneMapper v4.0 software. Fine mapping of the
disease-associated interval with microsatellite typing sug-
gested linkage to 10q23 (Figure 1) and excluded all other
candidate loci. Using the Superlink software,12 we obtained
amaximal LODscore of 4.11atmarkerD10S1687 (Figure3).
Haplotype analysis (Figure 1) revealed critical recombina-
tions in individuals II-3, II-6, and II-11, setting the disease
boundaries at markers D10S1174 and D10S520 (Figure 1).The AmThe 10.8 Mb interval was found to contain 124 genes of
which 28 were sequenced (Table S1, available online).
Of particular interest was a group of three genes encod-
ing epidermal acid lipases. At least six acid lipases are
involved in triglyceride hydrolysis in mammals and are
designated as lipase A (lysosomal; MIM 613497); lipase F
(gastric; MIM 601980); lipase J (testis); and lipases K, M,
and N, which are specifically expressed in the epidermis.13
Mammalian acid lipase genes have been shown to be clus-
tered in all mammals examined to date, suggesting that
they appeared through duplication during evolution.14
Although the National Center for Biotechnology Informa-
tion database contains two SNPs in LIPN predicted to result
in premature termination of translation (rs35519318 and
rs75379216), we were unable to identify these variants in
496 healthy controls, including 250 Arab Muslims, 46
Druzes, and 200 Europeans, suggesting that these SNPs
are either exceedingly rare or possibly nonexistant.
Genomic DNA was amplified by PCR by using primer
pairs spanning the entire coding sequence and all intron-
exon boundaries of LIPK, LIPM, and LIPN (Table S2) aserican Journal of Human Genetics 88, 482–487, April 8, 2011 483
Figure 2. Clinical Features
(A and B) Diffuse lamellar ichthyosis over
the legs of a 14-year-old affected individual
(patient II-1).
(C) A skin biopsy shows hyperkeratosis, or-
thokeratosis, hypergranulosis, and acan-
thosis (hematoxylin and eosin staining,
original magnification 1003).well as 25 additional genes (Table S1). PCR amplification
was performed with Taq polymerase. Cycling conditions
were 94C for 2 min followed by three sets of three cycles
each (set 1: 94C for 40 s, 61C for 40 s, and 72C for 40 s;
set 2: 94C for 40 s, 59C for 40 s, and 72C for 40 s; set 3:
94C for 40 s, 57C for 40 s, and 72C for 40 s); by 33 cycles
at 94C for 40 s, 55C for 40 s, and 72C for 40 s; and then
by a final extension step at 72C for 10 min. DNA was
extracted from gel, purified with QIAquick Gel Extraction
kit (QIAGEN), and submitted to direct sequencing with
the BigDye terminator system on an automated sequencer
(ABI PRISM 3100 Genetic Analyzer; Applied Biosystems,
Foster City, CA, USA).
Direct sequencing of the resulting PCR products
revealed a homozygous 2 bp deletion in exon 3 of LIPN,484 The American Journal of Human Genetics 88, 482–487, April 8, 2011encoding lipase member N, at posi-
tion 399–400 of the cDNA sequence
(c.399_400delGA; p.Glu133AspfsX3;
accession numbers NM_001102469.1,
NP_001095939.1) (Figure 4). To
confirm the mutation, we amplified
a 453 bp long DNA fragment with
forward primer 50- CTGTGATGTTT
CCGACATGC-30, and reverse primer
50- GCTTCTTGCTGTTACCCTCC-30
(Figure 1). The resulting amplicons
were digested with BsmAI endonucle-
ases and visualized with ethidium
bromide. Using this assay, weconfirmed segregation of the mutation throughout the
extended family and also assessed 925 healthy individuals
for themutation, including 679 individuals of ArabMuslim
origin, 46 Druzes, and 200 Ashkenazi Jews. One individual
of Arab Muslim extraction was found to carry mutation
c.399–400delGA in an heterozygous state. This individual
was found to share a common haplotype with affected
members of the family, possibly pointing to a founder effect
(not shown). Taken together, these results indicate that
p.Glu133AspfsX3 does not represent a common neutral
polymorphism but rather is a disease-causing mutation.
Mutation c.399–400delGA is predicted to result in the
generation of a stop codon two amino acids downstream
from the mutation site (p.Glu133AspfsX3), which in turn
is likely to lead to decreased LIPN mRNA levels because ofFigure 3. Multipoint Analysis of Lod
Score
Lod scores are plotted against the 15
markers assessed.
Figure 4. Mutation Analysis
Sequence analysis of LIPN reveals a homozygous deletion at cDNA
position 399_400 (upper panel, red arrow). The wild-type
sequence is given for comparison (lower panel).nonsense mediated mRNA decay. To assess this possibility,
we extracted total RNA from a patient’s skin biopsy by
using RNeasy Extraction Kit (QIAGEN). cDNA was synthe-
sized (Thermo Scientific VersoTM cDNA Synthesis Kit, UK)
and PCR amplified with exon-crossing primers located in
LIPN exons 6 and 8, respectively (50- TGAATCAGAGTCG
AATGGATGTG-30; 50- GTGGTAAAGCTGTTTTATATGCAG
AATG-30). Figure 5A shows that mutation c.399–400delGA
results in markedly decreased LIPN mRNA levels.
Acid lipases representa special groupof lipases that,unlike
theneutral lipases suchas liproprotein lipases, are capable of
withstanding acid conditions14 within organelles such as
lysosomes or in certain tissues, such as the gastric mucosa.
For example, lipase A catalyzes the deacylation of triacylgly-
cerols and cholesterol esters in lysosomal low-density
lipoproteins and has been associated with the pathogenesis
of several forms of lysosomal storage disease.15,16 Lipase F,
in contrast, is critical for proper catabolism of triglycerides
in the stomach.17 More limited information on the role of
other acid lipases is available. Three of these lipases, K, M
andN, have been shown to be expressed in the epidermis.13
All mammalian epidermal acid lipases seem to have been
extremely well conserved over more than 100million years
of evolution,14 suggesting their importance for the normal
maturation of stratified epithelia.
In line with previous semiquantitative RT-PCR experi-
ments,13 LIPN mRNA levels were significantly higher byThe Amquantitative RT-PCR in epidermal cells compared with
20 different tissues (Figure 5B). Although this pattern of
tissue-specific expression suggests involvement of lipase
N in the process of cornification, which was obviously
disturbed in our patients (Figure 2), we attempted to obtain
more direct evidence for lipase N involvement in epidermal
differentiation. At different time points during epidermal
stratification, we extracted total RNA from organotypic
cultures derived from primary human keratinocytes as
previously described18 and compared the expression of
LIPN to that of IVL andKRT10 (knownmarkers of epidermal
differentiation). Along with KRT10 and IVL, LIPN was
found to be upregulated during epidermal differentiation
(Figure 5C), suggesting that lipase N is part of the differenti-
ation program of human keratinocytes.
In summary, the present data indicate that decreased
expression of LIPN is associated with a late-onset form of
ARCI and add to the steadily growing list of genes related
to ARCI and encoding proteins involved in lipid metabo-
lism. Abnormal epidermal lipid metabolism has been
shown to underlie the pathogenesis of numerous forms
of ichthyosis,19,20 including X-linked recessive ichthyosis
(MIM 308100) due to deficient activity of steroid sulfa-
tase;21 harlequin ichthyosis due to decreased function
of the lipid transporter, ABCA12;22 ARCI caused by muta-
tions in genes encoding enzymes belonging to the hepox-
ylin pathway;23–25 and ichthyosis prematurity syndrome
(MIM 608649) caused by mutations in FATP4, encoding
fatty acid transport protein 4.26 Despite the critical impor-
tance of triglyceride metabolism for proper epidermal
maturation,25 the exact function of lipase N is unknown
at the present. However, it is of interest to note that
another syndromic form of congenital-recessive ichthyo-
sis, Chanarin-Dorfman syndrome (MIM 275630), has
been shown to be caused by mutations in ABHD5 (MIM
604780),27 which encodes a cofactor for adipose triglyc-
eride lipase, also known as patatin-like phospholipase
domain protein 2 (PNPLA2; MIM 609059).28,29 Recent
data obtained in a mouse model for this disease30 indicate
that ABHD5 targets epidermal lipases that are distinct from
PNPLA2. It is tempting to speculate that LIPNmay encode
one of these enigmatic epidermal lipases.Supplemental Data
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Figure 5. LIPN Expression Analysis
(A) Quantitative RT-PCRwas performed onmRNA samples extracted from keratinocyte cultures derived from a patient and a nonaffected
individual (control). Results are provided as a percentage of LIPN expression in control keratinocytes5 SD.
(B) LIPN expression was assessed via Clontech tissue blot cDNA array. Expression of LIPN was normalized to that of ACTB. Results are
provided as a percentage of LIPN expression in control keratinocytes5 SD. The following abbreviations are used: ESON ¼ esophagus;
S.INT ¼ small intestine; PLACEN ¼ placenta; TRACH ¼ trachea; PROST ¼ prostate; KC ¼ keratinocytes.
(C) Total RNA was extracted from organotypic cell cultures at day 0 (green), day 7 (blue), and day 10 (red). LIPN, IVL, and KRT10 expres-
sion were compared by using quantitative RT-PCR. Results are provided as a percentage of expression at day 0.Web Resources
The URLs for data presented herein are as follows:
dbSNP, http://www.ncbi.nlm.nih.gov/SNP/
Ensembl Genome Browser, http://www.ensembl.org/
GenBank, http://www.ncbi.nlm.nih.gov/Genbank/
GeneLoc, http://genecards.weizmann.ac.il/geneloc/index.shtml




UCSC Genome Browser, http://genome.ucsc.edu/References
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